First-Trimester Screening in Germany After the Introduction of NIPT as a General Health Insurance Benefit
Ultraschall in der Medizin - European Journal of Ultrasound · 01.06.2023 · 44 (03) · 327-328
DOI: 10.1055/a-2028-8108 ↗Kurz gefasst
Leserbrief in der Zeitschrift Ultraschall in der Medizin - European Journal of Ultrasound, erschienen am 01.06.2023. Verfasst von Bernd Eiben und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Laboratory Medicine and Human Genetics, Essen, Germany. Hauptthemen laut MEDLINE: Insurance Benefits, Down Syndrome. Die Arbeit wurde bisher 5-mal zitiert (Crossref).
Abstract (Originalsprache)
Prenatal non-invasive screening has been offered to pregnant women in Europe since the beginning of this century as first trimester screening (FTS) based on risk calculation programs of Fetal Medicine Foundation (FMF-UK) and FMF-Germany and has spread rapidly worldwide (Nicolaides KH et al. Br J Obstet Gynaecol. 1994;101:782–6, Merz E et al. Ultraschall in Med. 2022;43:115–119). First trimester screening is based on the combination of maternal age, crown rump-length, specific prenatal ultrasound markers such as fetal nuchal translucency (+ optional nasal bone, abnormal ductus venosus flow and tricuspid regurgitation) and the biochemical markers free β-hCG and PAPP-A, and calculates the individual risk for the 3 most common trisomies 13, 18 and 21. Furthermore, the required detailed ultrasound examination allows the detection of structural fetal abnormalities, early growth restriction, twin abnormalities and anomalies of the placenta (Merz E, Pashaj S. Embryonic and early fetal abnormalities diagnosed with three-dimensional ultrasound in the 1st trimester. In: Kurjak A, Chervenak F. Embryo as a person and as a patient. Jaypee Brothers Medical Publishers, New Delhi-London-Panama, 2020; pp. 51–64.2020), leading to a significant improvement in prenatal care beyond trisomies, as aneuploidies account only for 14.26 % of all fetal mal-formations (EUROCAT. https://eu-rd-platform.jrc.ec.europa.eu/eurocat/eurocat-data/preva-lence_en). Publication History Received: 09 January 2023 Accepted: 06 February 2023 Accepted Manuscript online: 06 February 2023 Article published online: 05 April 2023 © 2023. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Institute of Laboratory Medicine and Human Genetics, Essen, Germany.
- Molecular Genetics, Amedes Genetics, Hannover, Germany.
- amedes medizinische Dienstleistung, Hamburg, Germany.
- Obstetrics & Gynecology, Centre for Ultrasound and Prenatal Medicine, Frankfurt, Germany.
Zitieren
APA
Eiben, B., Glaubitz, R., Winkler, T., & Merz, E. (2023). First-Trimester Screening in Germany After the Introduction of NIPT as a General Health Insurance Benefit. Ultraschall in der Medizin - European Journal of Ultrasound, 44(03), 327-328. https://doi.org/10.1055/a-2028-8108
Vancouver
Eiben B, Glaubitz R, Winkler T, Merz E. First-Trimester Screening in Germany After the Introduction of NIPT as a General Health Insurance Benefit. Ultraschall in der Medizin - European Journal of Ultrasound. 2023;44(03):327-328. doi:10.1055/a-2028-8108
BibTeX
@article{Eiben2023,
author = {Eiben, Bernd and Glaubitz, Ralf and Winkler, Thomas and Merz, Eberhard},
title = {First-Trimester Screening in Germany After the Introduction of NIPT as a General Health Insurance Benefit},
journal = {Ultraschall in der Medizin - European Journal of Ultrasound},
year = {2023},
volume = {44},
number = {03},
pages = {327--328},
doi = {10.1055/a-2028-8108}
}
EUVIMED